Twirla - a new contraceptive patch
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:63 |
|---|---|
| Enthalten in: |
The Medical letter on drugs and therapeutics - 63(2021), 1617 vom: 08. Feb., Seite 17-18 |
| Sprache: |
Englisch |
|---|
| Anmerkungen: |
Date Completed 09.03.2021 Date Revised 09.03.2021 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM322046688 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM322046688 | ||
| 003 | DE-627 | ||
| 005 | 20231225181211.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n1073.xml |
| 035 | |a (DE-627)NLM322046688 | ||
| 035 | |a (NLM)33647003 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a Twirla - a new contraceptive patch |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.03.2021 | ||
| 500 | |a Date Revised 09.03.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Evra | |
| 650 | 4 | |a IUD | |
| 650 | 4 | |a Nexplanon | |
| 650 | 4 | |a Technivie | |
| 650 | 4 | |a Twirla | |
| 650 | 4 | |a Viekira Pak | |
| 650 | 4 | |a Xulane | |
| 650 | 4 | |a adverse effects | |
| 650 | 4 | |a contraceptives | |
| 650 | 4 | |a dosage | |
| 650 | 4 | |a drug interactions | |
| 650 | 4 | |a efficacy | |
| 650 | 4 | |a estrogens | |
| 650 | 4 | |a levonorgestrel | |
| 650 | 4 | |a ombitasvir | |
| 650 | 4 | |a oral contraceptives | |
| 650 | 4 | |a paritaprevir | |
| 650 | 4 | |a progestins | |
| 650 | 4 | |a ritonavir | |
| 650 | 4 | |a safety | |
| 650 | 7 | |a Contraceptive Agents, Hormonal |2 NLM | |
| 650 | 7 | |a Estradiol |2 NLM | |
| 650 | 7 | |a 4TI98Z838E |2 NLM | |
| 650 | 7 | |a Levonorgestrel |2 NLM | |
| 650 | 7 | |a 5W7SIA7YZW |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t The Medical letter on drugs and therapeutics |d 1965 |g 63(2021), 1617 vom: 08. Feb., Seite 17-18 |w (DE-627)NLM000074810 |x 1523-2859 |7 nnns |
| 773 | 1 | 8 | |g volume:63 |g year:2021 |g number:1617 |g day:08 |g month:02 |g pages:17-18 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 63 |j 2021 |e 1617 |b 08 |c 02 |h 17-18 | ||